RPRX
Royalty Pharma Plc
NASDAQ · Healthcare · Biotechnology · US
$58.41
−0.88%Forward multiples
Based on analyst estimates
- P/E forward
- 12.54x
- P/E 2026E
- 10.89x
- P/E 2027E
- 10.15x
- P/E 2028E
- 9.00x
- P/S forward
- 7.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.23x
- PEG TTM
- 0.26x
- Price / book
- 3.81x
- Price / sales
- 10.26x
- Price / cash flow
- 8.74x
Enterprise value
- Enterprise value
- $37.1B
- EV / sales
- 14.62x
- EV / EBITDA
- 21.61x
- EV / EBIT
- 23.46x
- Market cap
- $26.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026